OTC •
Healthcare •
Drug Manufacturers - General •
Quote as of 05/15/2026 15:10
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeOTC
Market Capitalization12,381 mln
Earnings Date05/29/2026
EPS
0.20
Marginal
P / E
20.30
Premium valuation
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.4
Borderline
Relative Strength
14
/ 100
Significantly lagging
Debt / Equity
0.02
Debt-free
Business Description
CSPC Pharmaceutical Group Limited is a China-based company founded in 1992 that manufactures and sells a broad range of medicines, including treatments for stroke, cancer, diabetes, infections, and pain, distributing its products across Asia, Europe, North America, and beyond. The company operates across several business areas, covering finished medicines, active pharmaceutical ingredients such as vitamin C and antibiotics, and functional food products. It also works with AstraZeneca to develop new oral treatments targeting obesity, type 2 diabetes, and other conditions. Headquartered in Shijiazhuang, China, the company is listed under its current name since 2013, having previously traded as China Pharmaceutical Group Limited.
